InsidersTradesSigma
Ascelia Pharma AB Stock: price and management transactions · Finland · FIN-FSA
Follow the Ascelia Pharma AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Ascelia Pharma AB has logged 8 reports. Market capitalisation: €393.3m. The latest transaction was reported on 26 November 2025 (Purchase). Among the most active insiders: Magnus Olafsson Corfitzen. The full history is free.
8
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ascelia Pharma AB Strong Buy (bullish), based on 4 analysts. Average price target: SEK 5.60.
36Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 26 November 2025
Declarations8 total
24,975 shares0AktieFI:A003U165-1
Ideal exit: 22 Aug 2026 (T+270)
1,754 shares0AktieFI:A003U157-1
Ideal exit: 22 Aug 2026 (T+270)
6,152 shares@ €0.19270.0003% mcap22.1% of flowAktieFI:A003N440-1
21,688 shares@ €0.19270.0011% mcap77.9% of flowWarrantFI:A003N439-1
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
10,000 shares@ €0.19270.0005% mcap100.0% of flowAktieFI:A003N414-1
100,000 shares@ €0.19270.0049% mcap100.0% of flowAktieFI:A003N410-1
112,500 shares0AktieFI:A001P652-2
539,685 shares0AktieFI:A001P626-2
8 of 8 declarations